Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Turkey
Department of Cardiovascular Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Eur J Hosp Pharm. 2024 Jun 21;31(4):332-338. doi: 10.1136/ejhpharm-2022-003669.
Optimal perioperative success in cardiac surgery requires precise management of drug treatment. This study aimed to determine the prevalence, types and associated factors of drug-related problems (DRPs) during the entire hospital stay.
A prospective observational study was conducted at the department of cardiovascular surgery in a university hospital between November 2019 and March 2020. Patients with planned elective cardiac surgery, aged ≥18 years, were included. A clinical pharmacist collaboratively reviewed medications on a daily basis and identified DRPs.
A total of 100 patients (60 male) were included; median (range) age was 62 (19-86) years, and median (IQR) length of stay in hospital was 15 (9) days. A total of 275 DRPs were identified (median (IQR) 3 (2-4)). The number of patients who had at least one DRP was 47 preoperatively, 55 in the postoperative intensive care unit, 100 in the postoperative ward, and 16 at discharge. In order to reduce bias because of the small sample size, Firth's logistic regression analysis was conducted. Statistically significant variables according to univariate analysis were included into a logistic regression model. Therefore the length of hospital stay (OR 1.14, 95% CI 1.03 to 1.26, p=0.008), living arrangements (living alone) (OR 4.24, 95% CI 1.41 to 12.73, p=0.009), number of medications at admission (OR 1.32, 95% CI 1.09 to 1.59, p=0.002), and having coronary artery bypass graft surgery (OR 2.87, 95% CI 1.07 to 7.70, p=0.03) were associated with an increased risk for DRPs in the final model.
Hospital stay carries an increased risk for DRPs, especially at the postoperative stage. Modifiable risk factors for DRPs can be managed by required interventions performed by a multidisciplinary healthcare team.
心脏外科手术围手术期的理想效果需要对药物治疗进行精确管理。本研究旨在确定整个住院期间药物相关问题(DRP)的发生率、类型和相关因素。
这是一项在 2019 年 11 月至 2020 年 3 月在一所大学医院心血管外科进行的前瞻性观察研究。纳入计划择期心脏手术、年龄≥18 岁的患者。临床药师每天协作审查药物并确定 DRP。
共纳入 100 例患者(60 例男性);中位(范围)年龄为 62(19-86)岁,中位(IQR)住院时间为 15(9)天。共确定了 275 例 DRP(中位数(IQR)3(2-4))。术前至少有 1 例 DRP 的患者为 47 例,术后重症监护病房 55 例,术后病房 100 例,出院时 16 例。为了减少因小样本量而产生的偏差,进行了 Firth 逻辑回归分析。根据单变量分析有统计学意义的变量被纳入逻辑回归模型。因此,住院时间(OR 1.14,95%CI 1.03 至 1.26,p=0.008)、居住安排(独居)(OR 4.24,95%CI 1.41 至 12.73,p=0.009)、入院时用药数量(OR 1.32,95%CI 1.09 至 1.59,p=0.002)和冠状动脉旁路移植术(OR 2.87,95%CI 1.07 至 7.70,p=0.03)与最终模型中 DRP 的发生风险增加相关。
住院时间与 DRP 的发生风险增加有关,尤其是在术后阶段。DRP 的可改变风险因素可以通过多学科医疗团队进行必要的干预来管理。